Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

Top 6 worries about healthcare AI among clinicians and patients in 2026
AI is now as much a part of U.S. healthcare as any other technology category in wide use across the sector. However, like no other technology, its role is “being actively shaped, not passively adopted” by clinicians and patients alike.
Connection uncovered between liability protections and downsizing decisions—in nursing homes, at least
When nursing homes lose their fear of getting sued for substandard care quality, they tend to make do with fewer caregivers, a new study reveals.
FDA highlights recall of certain Impella introducer kits after 3 injuries
This latest recall was put in place due to an increased risk of blood clots developing during use. Only a small number of hospitals are affected.
Medical societies respond after Trump administration questioned necessity of certain procedures
A recent OIG report suggested vascular surgeons, interventional cardiologists and interventional radiologists may be performing medically unnecessary procedures in office-based labs. Now, some of the leading medical societies from those fields have provided additional context.
When used in the ‘wild’ conditions of the real world, large language AI stumbles
Asking medical questions of AI with language spoken “in the wild”—meaning with LLM prompts from everyday consumers—brings back answers with decidedly mediocre accuracy, a new study shows.

Benzodiazepine use before heart surgery: Should it be embraced or restricted?

Benzodiazepines are administered before a majority of cardiac surgeries to lower the risk of intraoperative awareness. At the same time, however, recent studies have suggested they increase the risk of postoperative delirium.

AI brings cardiology, neurology teams together to boost care for stroke patients

A new post-stroke care pathway from Viz.ai and Medtronic is associated with significant benefits, including higher patient and clinician satisfaction.

The U.S. Food and Drug Administration (FDA) has shared a new warning about ongoing safety issues with atherectomy devices sold and distributed by Bard Peripheral Vascular, an Arizona-based subsidiary of Becton, Dickinson and Company (BD). The warning includes multiple models of Bard Peripheral Vascular’s Rotarex Atherectomy System, which is designed to target high-risk plaques and blood clots in the peripheral arteries by rotating at a high speed.

FDA warns that atherectomy devices are breaking during use—30 serious injuries, 4 deaths reported

More than 100 incidents have been reported so far. The FDA is still evaluating this issue, but the agency wanted to raise awareness as quickly as possible.

artificial intelligence AI in healthcare

Healthcare AI Digest

People are still asking if AI will replace doctors or other healthcare workers.

Healthcare systems are proceeding apace with GenAI—and learning as they go

Last summer more than 40% of 121 hospital executives surveyed said their organization had already realized a decent ROI in generative AI. However, a C-suite slice of nearly the same size said it was too soon to know for sure.

FDA warns that smartphone-compatible diabetes devices may not work properly

Smartphones have made it easier than ever for patients to monitor their own health, but the technology is far from infallible.

Heart failure patients see benefits from home-based rehab

Many heart failure patients still skip cardiac rehab altogether. Offering a home-based option could potentially help reverse that trend.

Healthcare AI Digest

Don’t judge DeepSeek on the innovativeness of its programming. Judge it on the degree to which it shakes up the economics of the AI market.

Care Delivery

Top 6 worries about healthcare AI among clinicians and patients in 2026

Connection uncovered between liability protections and downsizing decisions—in nursing homes, at least

FDA highlights recall of certain Impella introducer kits after 3 injuries

Medical societies respond after Trump administration questioned necessity of certain procedures

When used in the ‘wild’ conditions of the real world, large language AI stumbles